Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

AmberHealth vs PeterMD

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.7

AmberHealth

Best for budget-conscious shoppers
★★★3.9

Starting at $100/mo

CompoundedSemaglutideTirzepatide
Visit AmberHealth
7.2

PeterMD

Best for men seeking flat-priced compounded GLP-1 access alongside TRT or peptide therapy
★★★3.6

Starting at $135/mo

CompoundedSemaglutideTirzepatideMen's Health
Visit PeterMD

Side-by-Side Comparison

FeatureAmberHealthPeterMD
Overall Score7.7/107.2/10
Starting Price$100/mo$135/mo
Editorial Rating3.9 ★ /53.6 ★ /5
Features3 features6 features
States Available5042
Compounded✓ Yes✓ Yes
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

AmberHealth

Pros

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Cons

  • Limited public information on program details

PeterMD

Pros

  • Flat pricing across semaglutide dose tiers (0.25mg through 2.4mg)
  • Both semaglutide and tirzepatide available
  • No long-term commitment after the 2-month intro period
  • Month-to-month cancellation via patient portal, no cancellation fee
  • Covers men's-health adjacencies (TRT, peptides, ED, anti-aging) in one account

Cons

  • Initial $270 two-month payment is non-refundable
  • Not available in 8 states (AL, AR, CA, HI, ID, MI, NC, TX)
  • Men's-only branding — will not appeal to women seeking GLP-1 access
  • Pharmacy partner and named clinicians not publicly disclosed

Our Verdict

Winner: AmberHealthScore: 7.7/10

AmberHealth edges out PeterMD with a higher overall score of 7.7/10 and is particularly strong for budget-conscious shoppers. PeterMD remains a solid alternative, especially if you're looking for men seeking flat-priced compounded GLP-1 access alongside TRT or peptide therapy.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.